Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAPTYSBIO, INC Director's Dealing 2018

Aug 8, 2018

32596_dirs_2018-08-08_05e351b2-2fcf-4313-8826-7fcc3402aeb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2018-08-06

Reporting Person: LOUMEAU ERIC J (General Counsel)

Holdings (Non-Derivative)

Security Shares Ownership
No securities are beneficially owned 0 Direct